Multi‐class cancer subtype classification based on gene expression signatures with reliability analysis
- 24 February 2004
- journal article
- research article
- Published by Wiley in FEBS Letters
- Vol. 561 (1-3) , 186-190
- https://doi.org/10.1016/s0014-5793(04)00175-9
Abstract
Differential diagnosis among a group of histologically similar cancers poses a challenging problem in clinical medicine. Constructing a classifier based on gene expression signatures comprising multiple discriminatory molecular markers derived from microarray data analysis is an emerging trend for cancer diagnosis. To identify the best genes for classification using a small number of samples relative to the genome size remains the bottleneck of this approach, despite its promise. We have devised a new method of gene selection with reliability analysis, and demonstrated that this method can identify a more compact set of genes than other methods for constructing a classifier with optimum predictive performance for both small round blue cell tumors and leukemia. High consensus between our result and the results produced by methods based on artificial neural networks and statistical techniques confers additional evidence of the validity of our method. This study suggests a way for implementing a reliable molecular cancer classifier based on gene expression signatures.Keywords
This publication has 21 references indexed in Scilit:
- New gene selection method for classification of cancer subtypes considering within‐class variationFEBS Letters, 2003
- High-Throughput Tissue Microarray Analysis Used to Evaluate Biology and Prognostic Significance of the E-Cadherin Pathway in Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2002
- Diagnosis of multiple cancer types by shrunken centroids of gene expressionProceedings of the National Academy of Sciences, 2002
- Selection bias in gene extraction on the basis of microarray gene-expression dataProceedings of the National Academy of Sciences, 2002
- Multiclass cancer diagnosis using tumor gene expression signaturesProceedings of the National Academy of Sciences, 2001
- Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential22Abbreviations: ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; Cy, Cyanine; DLCL, diffuse large cell lymphoma; dNTPs, deoxyribonucleotides; ESTs, expressed sequence tags; mRNA, messenger RNA; NHL, non-Hodgkin’s lymphoma; ORF, open reading frame; RT-PCR, reverse transcription-polymerase chain reaction; and 17AAG, 17-allylamino,17-demethoxygeldanamycin.Biochemical Pharmacology, 2001
- Feature (Gene) Selection in Gene Expression-Based Tumor ClassificationMolecular Genetics and Metabolism, 2001
- DNA microarray technology to revolutionise cancer treatmentThe Lancet Oncology, 2001
- Distinctive gene expression patterns in human mammary epithelial cells and breast cancersProceedings of the National Academy of Sciences, 1999
- Support-vector networksMachine Learning, 1995